VIM and prostate cancer: Cajigas-du Ross et al., [246] for example, performed RNA-seq on docetaxel-resistant and -sensitive prostate cancer cells and found that E-cadherin levels were significantly reduced, while there was an increase in vimentin, SNAIL and TWIST levels in docetaxel-resistant prostate cancer cell lines [246].